1. Home
  2. OSW vs TRVI Comparison

OSW vs TRVI Comparison

Compare OSW & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpaWorld Holdings Limited

OSW

OneSpaWorld Holdings Limited

HOLD

Current Price

$28.20

Market Cap

2.4B

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$18.15

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSW
TRVI
Founded
2017
2011
Country
Bahamas
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
OSW
TRVI
Price
$28.20
$18.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$27.00
$21.55
AVG Volume (30 Days)
802.3K
1.6M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
31.91
EPS
0.21
N/A
Revenue
$961,001,000.00
N/A
Revenue This Year
$7.49
N/A
Revenue Next Year
$8.52
N/A
P/E Ratio
$129.81
N/A
Revenue Growth
7.37
N/A
52 Week Low
$19.06
$5.41
52 Week High
$29.25
$18.16

Technical Indicators

Market Signals
Indicator
OSW
TRVI
Relative Strength Index (RSI) 69.73 72.77
Support Level $19.70 $10.07
Resistance Level N/A N/A
Average True Range (ATR) 1.16 0.87
MACD 0.27 0.38
Stochastic Oscillator 82.98 94.10

Price Performance

Historical Comparison
OSW
TRVI

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: